Mold-Tek Packaging Limited

rs,

L/SECT/31/2025-26 To The Secretary, Listing Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Scrip Code: 533080 Dear Sir/Madam, Sub: Investor Presentati

100%

A Pioneers in the field of In-Mold labelling (IML) in India. HD photographic labels, produced by 100% hands-free operation & are 100% recyclable. MTPL commands strong presence across all major custo

11.37%

The demand is continually growing and new addition are encouraging Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae

45%

nd new addition are encouraging Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae MQIFY'25 MQ2FY'25 mQ3F ae Phar

Rs.6.66

addition are encouraging Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae MQIFY'25 MQ2FY'25 mQ3F ae Pharma Sales

Rs.2.27

encouraging Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae MQIFY'25 MQ2FY'25 mQ3F ae Pharma Sales MQ4FY'25 m

Rs.0.79

g Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae MQIFY'25 MQ2FY'25 mQ3F ae Pharma Sales MQ4FY'25 mQi1FY26 Cli

Rs.1.02

pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr. Rs.2.27Cr. Rs.0.79Cr. Rs.1.02Cr. — el ae MQIFY'25 MQ2FY'25 mQ3F ae Pharma Sales MQ4FY'25 mQi1FY26 Clientele a

11,378MT

2025 Snapshot a Financial Performance & Highlights Sales Volume The Sales Volume recorded 11,378MT in QIFY26 against 9,894MT in QIFY25 - a growth of 15%. Revenue The Company recorded a total re

9,894MT

cial Performance & Highlights Sales Volume The Sales Volume recorded 11,378MT in QIFY26 against 9,894MT in QIFY25 - a growth of 15%. Revenue The Company recorded a total revenue of INR 240.55 cr. in

15%

Sales Volume The Sales Volume recorded 11,378MT in QIFY26 against 9,894MT in QIFY25 - a growth of 15%. Revenue The Company recorded a total revenue of INR 240.55 cr. in QIFY26, compared to INR 196

INR 240.55

6 against 9,894MT in QIFY25 - a growth of 15%. Revenue The Company recorded a total revenue of INR 240.55 cr. in QIFY26, compared to INR 196.72 cr. in last year —- a growth of 22% +29.21% EBIDTA INR

“In Q4 of FY25 Q1 Update * Moldtek’s reputation in IML, combined with DMF facility with greatest hygiene standards has helped us to dominate the EV tubes and stoppers market for Nutraceuticals * The demand is continually growing and new addition are encouraging Q1 vs Q4 pharma growth is 11.37% reflecting annualized rate at 45% Rs.6.66Cr.”

Registered and Corporate Office

1

Registered and Corporate Office

8-2-293/82/A/700, Road No.36, Jubilee Hills, Hyderabad — 500033, Telangana, India Phone: +91-40-40300300, E-mail Id: cs@moldtekpackaging.com / ir@moldtekpackaging.com, Website: www.moldtekpackaging.com, CIN No.: L21022TG1997PLC026542 ‘2 MOLD-TEK mms Packaging Limited QI FY 25-26 Presentation (BSE: 533080; NSE: MOLDTKPAC) July 28, 2025 Moldtek Snapshot 7 YEARS OF EXPERIENCE ISO CERTIFIED 10 UNITS NSE 3SE PUBLICLY LISTED WITH INR ~ 2460 Cr Market cap Established in 1986, one of the leading players in rigid plastic packaging in India. Publicly listed in 1993 10 Manufacturing Units, 2 stock points PAN India. Current installed Injection molding capacity of over 63,000 TPA Pioneers in the field of In-Mold labelling (IML) in India. HD photographic labels, produced by 100% hands-free operation & are 100% recyclable. MTPL commands strong presence across all major customers like Asian Paints, Castrol, Shell, Mondelez, Hindustan Unilever, etc. Superior margins in the packaging industry due to the